Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 490 followers
Latest posts
Last updated 1 day ago
GSK announces Dr Gavin Screaton to join the Board as Non-Executive Director
1 day ago
GSK plc has today announced that Dr Gavin Screaton has been appointed...
Nucala (mepolizumab) application for COPD accepted for review in China
2 days ago
Around 100 million people live with COPD in China, accounting for almost...
Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY
7 days ago
Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A...
GSK delivers strong 2024 performance with further improvement to long-term growth outlook
17 days ago
Q4 and full year 2024 performance highlights
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents
22 days ago
Vocabria + Rekambys (cabotegravir + rilpivirine) is the first and only complete...
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP
25 days ago
If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing.
Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP
25 days ago
If approved, depemokimab will be the first ultra-long-acting biologic with 6-month dosing
GSK and Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
26 days ago
Collaboration unites GSK and Oxford’s complementary expertise in the science of the...
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
26 days ago
Over 25 million people in Europe have received GSK’s shingles vaccine since...
European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer
about 1 month ago
Expanded approval includes MMRp/MSS tumours, which represent approximately 75% of endometrial cancer...
GSK enters agreement to acquire IDRx, Inc.
about 1 month ago
Acquisition adds to GSK’s growing portfolio in gastrointestinal (GI) cancers
GSK’s Shingrix new prefilled syringe presentation accepted for review by US FDA
about 1 month ago
If approved, the new presentation will offer a convenient administration option to...